END-OF-TREATMENT QUANTITATIVE HBsAg < 500 IU/ML CAN PREDICT SUSTAINED REMISSION AND HBsAg LOSS AFTER DISCONTINUATION OF NUCLEOS(T)IDE ANALOGUES IN CHRONIC HEPATITIS B

Abdurakhmanov D. ¹ , Panevkina S. ² , Ibragimov E. ¹ , Rozina T. ^{2, 1} , Nikulkina E. ¹ , Mazurchik N. ³

HEPATOLOGY

WILEY-BLACKWELL

English

Published

72

2020

• ¹ Sechenov First Moscow State Med Univ, Moscow, Russia
• ² Lomonosov Moscow State Univ, Moscow, Russia
• ³ Rudn Univ, Fac Med, Moscow, Russia